Standard Chemical & Pharmaceutical Co Ltd (TW:1720) — Market Cap & Net Worth
Market Cap & Net Worth: Standard Chemical & Pharmaceutical Co Ltd (1720)
Standard Chemical & Pharmaceutical Co Ltd (TW:1720) has a market capitalization of $315.84 Million (NT$10.02 Billion) as of September 17, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #14615 globally and #601 in its home market, demonstrating a -0.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Standard Chemical & Pharmaceutical Co Ltd's stock price NT$56.10 by its total outstanding shares 178696000 (178.70 Million). Also see 1720 asset base for a full breakdown of the balance sheet.
Standard Chemical & Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Standard Chemical & Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $154.88 Million to $315.84 Million (8.52% CAGR). Also see how efficiently does Standard Chemical & Pharmaceutical Co Lt generate cash for how efficiently the company converts equity into cash flow.
Standard Chemical & Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Standard Chemical & Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Standard Chemical & Pharmaceutical Co Lt (1720) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.05x
Standard Chemical & Pharmaceutical Co Ltd's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.40x
Standard Chemical & Pharmaceutical Co Ltd's market cap is 0.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $154.88 Million | $3.32 Billion | $347.89 Million | 0.05x | 0.45x |
| 2016 | $135.75 Million | $3.67 Billion | $340.22 Million | 0.04x | 0.40x |
| 2017 | $154.05 Million | $3.85 Billion | $363.29 Million | 0.04x | 0.42x |
| 2018 | $141.72 Million | $3.57 Billion | $374.36 Million | 0.04x | 0.38x |
| 2019 | $158.71 Million | $3.94 Billion | $376.48 Million | 0.04x | 0.42x |
| 2020 | $183.98 Million | $4.31 Billion | $524.17 Million | 0.04x | 0.35x |
| 2021 | $220.30 Million | $4.60 Billion | $706.73 Million | 0.05x | 0.31x |
| 2022 | $332.05 Million | $5.85 Billion | $1.15 Billion | 0.06x | 0.29x |
| 2023 | $371.01 Million | $6.24 Billion | $834.89 Million | 0.06x | 0.44x |
| 2024 | $348.49 Million | $6.79 Billion | $880.50 Million | 0.05x | 0.40x |
Competitor Companies of 1720 by Market Capitalization
Companies near Standard Chemical & Pharmaceutical Co Ltd in the global market cap rankings as of September 17, 2026. Review how tangible is Standard Chemical & Pharmaceutical Co Lt's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Standard Chemical & Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Standard Chemical & Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Standard Chemical & Pharmaceutical Co Ltd's market cap moved from $154.88 Million to $ 315.84 Million, with a yearly change of 8.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$315.84 Million | -4.75% |
| 2025 | NT$331.60 Million | -4.85% |
| 2024 | NT$348.49 Million | -6.07% |
| 2023 | NT$371.01 Million | +11.73% |
| 2022 | NT$332.05 Million | +50.73% |
| 2021 | NT$220.30 Million | +19.74% |
| 2020 | NT$183.98 Million | +15.93% |
| 2019 | NT$158.71 Million | +11.98% |
| 2018 | NT$141.72 Million | -8.00% |
| 2017 | NT$154.05 Million | +13.48% |
| 2016 | NT$135.75 Million | -12.35% |
| 2015 | NT$154.88 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Standard Chemical & Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $315.84 Million USD |
| MoneyControl | $315.84 Million USD |
| MarketWatch | $315.84 Million USD |
| marketcap.company | $315.84 Million USD |
| Reuters | $315.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Standard Chemical & Pharmaceutical Co Ltd
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, med… Read more